| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
| There are 7 registered members and 75 guests viewing the site. | Follow us on Twitter | Rss Top Picks Feed | Rss Daily Feed |
|
| SPECULATIVE BUY | 3.560 | Robert McWhirter | Very interesting biotechnology targeted to MS. Ranks well in his model at 15 because of the strong performance of the stock. Early-stage company. | 2009-01-26 | |
| Comment | 3.720 | Hugh Cleland, CFA | In phase 3 pivotal trial for secondary progressive MS and about a year away from getting data. Just got FDA approval to start trials in the US. Very high Risk and very high Reward. | 2007-01-24 |